GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CERo Therapeutics Holdings Inc (NAS:CERO) » Definitions » Institutional Ownership

CERo Therapeutics Holdings (CERo Therapeutics Holdings) Institutional Ownership : 0.07% (As of May. 26, 2024)


View and export this data going back to 2024. Start your Free Trial

What is CERo Therapeutics Holdings Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, CERo Therapeutics Holdings's institutional ownership is 0.07%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, CERo Therapeutics Holdings's Insider Ownership is 6.74%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, CERo Therapeutics Holdings's Float Percentage Of Total Shares Outstanding is 74.04%.


CERo Therapeutics Holdings Institutional Ownership Historical Data

The historical data trend for CERo Therapeutics Holdings's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CERo Therapeutics Holdings Institutional Ownership Chart

CERo Therapeutics Holdings Historical Data

The historical data trend for CERo Therapeutics Holdings can be seen below:

2024-01-31 2024-02-29 2024-03-31 2024-04-30
Institutional Ownership 0.10 0.07 0.07 0.07

CERo Therapeutics Holdings Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


CERo Therapeutics Holdings (CERo Therapeutics Holdings) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
201 Haskings Way, Suite 230, San Francisco, CA, USA, 94080
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

CERo Therapeutics Holdings (CERo Therapeutics Holdings) Headlines